Artificial Sweeteners and Intermittent Fasting

Artificial sweeteners and intermittent fasting are frequently combined, yet questions remain about whether sweeteners disrupt the fasted state. Most zero-calorie sweeteners contribute no meaningful calories, but fasting goals vary widely, from simple caloric restriction to autophagy or blood glucose control, and the impact of sweeteners differs across these contexts. This article examines whether sweeteners break a fast, how they affect insulin and blood sugar, which options are best studied, and what the current evidence actually shows, drawing on UK regulatory guidance and clinical recommendations.

Do artificial sweeteners break a fast?

Zero-calorie sweeteners do not break a fast in the caloric sense, but whether they disrupt a metabolic or autophagy-focused fast remains uncertain due to limited human evidence.

Whether artificial sweeteners break a fast depends on the definition of fasting being used, and the answer differs depending on whether the goal is caloric restriction, metabolic rest, or autophagy. Most zero-calorie sweeteners, such as aspartame, sucralose, saccharin, and stevia, contribute negligible or no calories and therefore do not break a fast in the strict caloric sense.^[1] However, fasting means different things in different contexts: a religious or water-only fast is broken by any additive, whereas a metabolic or weight-management fast is typically defined by the absence of meaningful caloric intake.

From a physiological standpoint, the key question is whether a sweetener triggers a metabolic response significant enough to disrupt the fasted state. Autophagy, the cellular self-cleaning process often cited as a benefit of prolonged fasting, may theoretically be sensitive to certain compounds, though robust human evidence on this specific point remains limited. For most people practising intermittent fasting for weight management or blood glucose control, consuming a calorie-free sweetened drink is unlikely to meaningfully interrupt the fast, though this cannot be stated with certainty given the current evidence base.

It is worth noting that individual responses to sweeteners can vary. Some people report hunger stimulation or cravings after consuming sweet-tasting drinks, even without calories, which may indirectly affect adherence to a fasting protocol.

Intermittent fasting is not appropriate for everyone. People who are pregnant or breastfeeding, under 18, living with an eating disorder, frail or older adults, and those with type 1 diabetes or who use diabetes technology should not begin a fasting regimen without first discussing it with their GP or specialist. People with type 2 diabetes who are on insulin or sulfonylureas face a risk of hypoglycaemia during fasting that requires medical supervision and possible medication adjustment. If the goal of fasting is metabolic or therapeutic, speaking with a GP or registered dietitian before incorporating sweeteners is advisable, particularly for those managing conditions such as type 2 diabetes or insulin resistance. Diabetes UK publishes patient-facing guidance on fasting with diabetes, including advice on hypoglycaemia risk and when to seek help.

How do sweeteners affect insulin and blood sugar during fasting?

Most non-nutritive sweeteners produce little to no meaningful rise in blood glucose or insulin, though sucralose may augment insulin response in some studies, particularly when consumed in liquid form.

The effect of artificial sweeteners on insulin and blood glucose during fasting is modest for most commonly used sweeteners, though the picture is not entirely straightforward. Non-nutritive sweeteners such as aspartame, saccharin, and acesulfame-K have generally been shown in short-term studies to produce little to no meaningful rise in blood glucose or insulin in healthy adults. Stevia, a plant-derived sweetener, has similarly demonstrated a neutral to mildly beneficial effect on postprandial glucose in some small trials, though the evidence base is limited.

Sucralose presents a more nuanced picture. Some research suggests that sucralose consumed in liquid form, particularly when combined with carbohydrates, may augment the insulin response compared with water alone, though findings are inconsistent across studies.^[12] The mechanism proposed involves cephalic phase insulin release, a reflex triggered by sweet taste receptors in the mouth and gut, which may prompt a small anticipatory insulin secretion even in the absence of glucose.^[2][3] However, the clinical significance of this response during a fasting window remains uncertain.

For individuals fasting to manage blood glucose, such as those with prediabetes or type 2 diabetes, the practical impact of sweetener-induced insulin fluctuations is likely small but should not be dismissed without professional guidance. NICE guidance on type 2 diabetes management (NG28) emphasises individualised dietary advice, and any significant changes to dietary habits during fasting, including sweetener use, are best discussed with a healthcare professional.^[5]

People taking insulin or sulfonylureas should be particularly cautious, as fasting itself carries a risk of hypoglycaemia that warrants medical supervision. People taking SGLT2 inhibitors (such as dapagliflozin, empagliflozin, or canagliflozin) should be aware that prolonged fasting, reduced carbohydrate intake, or intercurrent illness can increase the risk of diabetic ketoacidosis, which may occur even when blood glucose appears near-normal. Anyone on these medicines should seek medical advice before starting a fasting regimen. Diabetes UK provides patient-facing guidance on fasting safely with diabetes, including advice on medication adjustment and when to seek urgent help.

Which artificial sweeteners are considered well-studied options during a fasting window?

Stevia, aspartame, acesulfame-K, saccharin, and sucralose are the most extensively studied options and are all authorised as safe in Great Britain within established acceptable daily intakes.

No single artificial sweetener is universally recommended during a fasting window, but several are widely considered to have the least disruptive effect on fasting physiology based on current evidence. Stevia, derived from the Stevia rebaudiana plant, is frequently cited as a well-tolerated option. It is calorie-free and does not raise blood glucose at typical dietary intakes. Some small studies suggest it may have a neutral or mildly beneficial effect on insulin sensitivity, though the evidence is not conclusive.

Among synthetic sweeteners, aspartame, acesulfame-K, saccharin, and sucralose are among the most extensively studied. In Great Britain, food additive authorisation sits with the Food Standards Agency (FSA) and Food Standards Scotland (FSS) under assimilated food additive law; the European Food Safety Authority (EFSA) performs scientific safety evaluations that inform acceptable daily intakes (ADIs) across the EU, and JECFA (the joint FAO/WHO expert committee) provides international assessments.^[7] All four sweeteners named above are authorised for use in food and drink in Great Britain and are considered safe at intakes within their established ADIs. The FSA publishes consumer and technical summaries of sweetener approvals and ADIs for those seeking further detail.

Monk fruit extract (luo han guo) is a naturally derived, zero-calorie option that appears to have minimal impact on blood glucose in available studies. However, its regulatory status as a high-intensity sweetener in Great Britain differs from that in the United States, and consumers should check current FSA guidance on its authorised uses before relying on it as a sweetener.^[8]

Sucralose is widely used and generally regarded as safe, though as noted above, some evidence suggests it may have a slightly greater effect on insulin response than other sweeteners, particularly in liquid form. For this reason, some practitioners advise caution with sucralose during a strict metabolic fast.

Practically speaking, the most straightforward approach during a fasting window is to prioritise plain water, black coffee, or plain tea. If sweeteners are used, choosing a well-studied, zero-calorie option in small quantities is a reasonable strategy. Individuals with specific health conditions should seek personalised advice from their GP or a registered dietitian before making changes to their fasting routine. The British Dietetic Association (BDA) Food Fact Sheet on sweeteners provides a clear patient-facing summary of safety and use in a UK context.

What does the current evidence say about sweeteners and fasting outcomes?

Robust evidence specific to sweeteners combined with intermittent fasting is currently lacking; the WHO (2023) advises against sweeteners for long-term weight control in people without diabetes.

The current evidence on artificial sweeteners and intermittent fasting outcomes is limited, mixed, and largely drawn from studies that were not designed specifically to examine fasting protocols. Most of the available research examines sweetener use in the context of general caloric restriction or habitual dietary intake rather than time-restricted eating or alternate-day fasting. This makes it difficult to draw firm conclusions about how sweeteners specifically affect fasting outcomes such as weight loss, insulin sensitivity, or metabolic markers.

A randomised controlled trial published in the BMJ (Lohner et al., 2022) examined non-nutritive sweeteners including stevia and sucralose and found no significant effect on body weight, blood pressure, or glycaemic markers compared with sugar or water over a 12-week period in adults with overweight. This study did not examine fasting protocols specifically, and its findings should be interpreted in that context.

The World Health Organisation (WHO) issued a guideline in 2023 advising against the use of non-sugar sweeteners for weight control in people without pre-existing diabetes, citing evidence that long-term use does not confer sustained weight management benefits and may be associated with increased risk of type 2 diabetes and cardiovascular events in observational data.^[9] The WHO acknowledged that the evidence base has important limitations, including reverse causality, and noted that the guideline was not directed at people already living with diabetes. The full WHO 2023 guideline on non-sugar sweeteners is available for those wishing to review the primary source.

For those combining sweeteners with intermittent fasting, the honest summary is that robust, high-quality evidence specific to this combination is currently lacking. Sweeteners are unlikely to negate the benefits of fasting entirely, but they may not be entirely neutral either, particularly for gut microbiome health, where some animal studies and early, heterogeneous human data suggest possible effects. This area of research is preliminary and conclusions should not be overstated.

Individuals seeking structured support for weight management, including guidance on fasting and dietary choices, may benefit from a clinical consultation. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, where clinically appropriate options can be discussed. Anyone with underlying health conditions should speak with their GP before starting an intermittent fasting regimen.

Frequently Asked Questions